Guyana vs Oman: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Guyana
99.0%
in 2025
Oman
99.0%
in 2025
Guyana rank
1st
Oman rank
1st
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Guyana
- Oman
How they compare
Guyana currently reports 99.0% against 99.0% in Oman, a difference of 0.0%.
Across all 18 years both countries report, Oman has been ahead every year.
Guyana ranks 1st and Oman ranks 1st of 194 countries.
Oman has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Guyana | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 48.0% | 48.0% | Oman |
| 2010s | 80.5% | 98.8% | 18.3% | Oman |
| 2020s | 96.2% | 98.7% | 2.5% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Guyana or Oman?
- Guyana, at 99.0% against 99.0% in Oman as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Guyana and Oman?
- 0.0%, with Guyana ahead.
- How many years of comparable data are there for Guyana and Oman?
- 18 years are reported by both, from 2008 to 2025.
- How do Guyana and Oman rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Guyana ranks 1st and Oman ranks 1st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.